| Drug Name |
Clevidipine |
| Drug ID |
BADD_D00482 |
| Description |
Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option. |
| Indications and Usage |
For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable. |
| Marketing Status |
approved; investigational |
| ATC Code |
C08CA16 |
| DrugBank ID |
DB04920
|
| KEGG ID |
D08892
|
| MeSH ID |
C118563
|
| PubChem ID |
153994
|
| TTD Drug ID |
D09ELP
|
| NDC Product Code |
33656-0013; 50137-2930; 18124-011 |
| UNII |
19O2GP3B7Q
|
| Synonyms |
clevidipine | butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | Cleviprex |
